Thromboembolism Circulatory System Arterial embolism and thrombosis
Conditions
Interventions
Randomised controlled trial.
Random allocation to receive:
1. Enoxaparin
2. Tinaparin
Sponsors
Department of Health
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Pregnant patients with moderate risks of venous thromboembolism 2. Patients with history of recurrent miscarriage 3. Patients on low dose aspirin will be included as this has been shown not to adversely affect their TEG variables
Exclusion criteria
Exclusion criteria: 1. Subjects who have been admitted to hospital and are able to maintain their self catheterization regime 2. Subjects with symptomatic urinary tract infection, who are currently undergoing chemotherapy, radiation or steroid therapy, who self catheterize only once a day
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| We propose to compare the coagulation profiles of enoxaparin and tinaparin. We will use TEG and anti Xa activity to monitor effects. | — |
Secondary
| Measure | Time frame |
|---|---|
| Not provided at time of registration | — |
Countries
United Kingdom
Outcome results
None listed